Andreas Halvorsen - Viking Global Investors
Holding/activity history for Blueprint Medicines Corp (BPMC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | 0.06 | SEC | ||
| 2021 Q1 | 213,050 | 0.06 | Reduce 21.87% | 0.02 | $97.23 | $20,715,000 | SEC |
| 2020 Q4 | 272,681 | 0.08 | Reduce 80.94% | 0.39 | $112.15 | $30,581,000 | SEC |
| 2020 Q3 | 1,430,767 | 0.48 | Reduce 12.21% | 0.07 | $92.70 | $132,632,000 | SEC |
| 2020 Q2 | 1,629,716 | 0.55 | Add 1.83% | <0.01 | $78.00 | $127,118,000 | SEC |
| 2020 Q1 | 1,600,467 | 0.49 | Add 22.50% | 0.09 | $58.48 | $93,595,000 | SEC |
| 2019 Q4 | 1,306,541 | 0.49 | Add 62.98% | 0.19 | $80.11 | $104,667,000 | SEC |
| 2019 Q3 | 801,639 | 0.31 | Add 45.48% | 0.10 | $73.47 | $58,896,000 | SEC |
| 2019 Q2 | 551,040 | 0.23 | Reduce 16.34% | 0.05 | $94.33 | $51,980,000 | SEC |
| 2019 Q1 | 658,661 | 0.30 | Reduce 45.13% | 0.17 | $80.05 | $52,726,000 | SEC |
| 2018 Q4 | 1,200,322 | 0.38 | Add 980.40% | 0.34 | $53.91 | $64,709,000 | SEC |
| 2018 Q3 | 111,100 | 0.05 | Buy | 0.05 | $78.06 | $8,672,000 | SEC |